Mirum Pharmaceuticals, Inc. MIRM Work in process
Work in process at other companies
Other financials
Where this comes from
Reported directly by Mirum Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InventoryWorkInProcess.
The official record: Mirum Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Mirum Pharmaceuticals, Inc.'s work in process.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Mirum Pharmaceuticals, Inc.'s work in process?
- Mirum Pharmaceuticals, Inc. (MIRM) reported work in process of $19.49M in Q1 2026.
- How has Mirum Pharmaceuticals, Inc.'s work in process changed year-over-year?
- Mirum Pharmaceuticals, Inc.'s work in process increased by 23.2% year-over-year, from $15.82M to $19.49M.
- What is the long-term trend for Mirum Pharmaceuticals, Inc.'s work in process?
- Over 2 years (2023 to 2025), Mirum Pharmaceuticals, Inc.'s work in process has grown at a 36.8% compound annual growth rate (CAGR), from $9.87M to $18.47M.
- What does work in process mean?
- Partially completed goods currently in the manufacturing process, including materials, labor, and overhead costs incurred to date.